ENHYPEN Announce BLOOD SAGA 2026-27 World Tour
By Hasan Beyaz
Three weeks on from the announcement that changed their lineup, ENHYPEN have revealed what comes next. BLOOD SAGA, their upcoming world tour, spans 21 cities across five continents and runs from May 2026 through March 2027 – one of the most expansive routings of their career, with more dates still to be confirmed.
The tour opens in Seoul in early May, moves through Latin America and the United States across July and August, then continues into Macau in October, Japan across December through February, and closes out with a European run – Milan, Paris, Amsterdam, Berlin, London – before finishing in Singapore in March 2027. The scale is significant. For a fourth-generation act consolidating their global footprint, a routing that stretches this far signals a level of commercial confidence that most of their peers have not yet reached.
The poster, though, is the real story. Six silhouettes against a blood-red sky. It is the first official image of ENHYPEN since Heeseung's departure earlier this month, and it does the work a press release cannot – it shows, rather than tells, what the group looks like now. For fans still processing the news, the image will sting. The visual identity of the post-Heeseung era is being established quickly and on a very large stage.
That context is impossible to separate from the announcement entirely. BLOOD SAGA was almost certainly in planning long before March 10 – world tours of this scale are plotted months in advance. The timing of its release, weeks after the departure rather than alongside it, suggests the label needed breathing room before pivoting to promotion. The reason for that gap is hard to know. Either way, the message the tour announcement sends is clear enough: ENHYPEN is moving forward, and they are doing it loudly.
What BLOOD SAGA sounds and looks like in practice – the setlist, the formations, the roles redistributed across six – remains to be seen. The group's last release, THE SIN : VANISH, sold over two million copies in its first week and debuted at No. 2 on the Billboard 200. The fanbase is large, the demand is real, and the appetite for live shows is not going to evaporate over a lineup change. But a world tour is also the most exposed ENHYPEN will have been since the news broke. Seoul in May will be the first real answer.